FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and concerns methods of treating, relieving symptoms and prolonging a remission interval of autoimmune diseases of peripheral nervous system, particularly Guillain-Barre syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), neuropathy accompanying vasculitis. An effective amount of a sphingosine-1-phosphate receptor agonist, particularly FTY720, FTY720-P, AAL(R), AFD(R) or SEW2871 is introduced in a patient.
EFFECT: group of inventions provide extending the range of methods for treating autoimmune diseases of the peripheral nervous system.
20 cl, 10 dwg, 1 tbl, 5 ex
